FGFR3 and silicosis: Importantly, MSC-derived exosomes deliver miR-99a-5p to fibroblasts and inhibit fibroblast transdifferentiation by targeting FGFR3 and regulating MAPK signalling, which indicates that they could be promising candidates for the development of silicosis therapies.